Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-20
TNBC
Basal A
GW843682X
PLK
PLK
10581.139
uM
inf
inf
0.8086 0.8086 0.0000 0.1131
0.1274
1.1488
SUM229PE
TNBC
-
Cetuximab
EGFR
ErbB
9860.125
uM
inf
inf
0.8773 0.8773 0.0000 0.0289
0.1275
1.6001
HCC3153
TNBC
Basal A
Purvalanol A
CDK1
CDK
7466.067
uM
inf
inf
0.9484 0.9484 0.0000 -0.0204
0.1276
0.9457
UACC-812
HER2amp
Luminal
Baicalein
Lipoxygenase
Metabolism
7547.072
uM
inf
inf
0.6965 0.6965 0.0000 0.2408
-0.1290
0.8636
BT-474
HER2amp
Luminal
Glycyl-H-1152
ROCK2
12291.169
uM
inf
inf
0.8955 0.8955 0.0000 -0.0374
0.1290
0.3548
Hs 578T
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7474.095
uM
inf
inf
0.8203 0.8203 0.0000 0.0493
-0.1291
2.8423
MDA-MB-134-VI
HR+
Luminal
FR180204
ERK1/2
MAPK
12206.161
uM
inf
inf
0.6658 0.6658 0.0000 0.0853
0.130
1.0580
Hs 578T
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7475.091
uM
inf
inf
1.0500 1.0500 0.0000 -0.0020
0.1302
2.6839
AU565
HER2amp
Luminal
Selumetinib
MEK
MAPK
10880.155
uM
inf
inf
1.0500 1.0500 0.0000 -0.0108
-0.1312
1.5205
HCC3153
TNBC
Basal A
GM6001
MMP
MMP
7466.096
uM
inf
inf
0.8967 0.8967 0.0000 0.0827
-0.1319
0.9269
SUM149PT
TNBC
Basal B
Dichloroacetate
PDK
PDK
13123.176
uM
inf
inf
0.6345 0.6345 0.0000 0.1874
0.1319
1.1020
HCC1954
HER2amp
Basal A
Vinorelbine
TUBB
TUBB
7835.018
uM
inf
inf
-0.9999 -0.9999 0.0000 0.8246
0.1320
0.5326
MDA-MB-175-VII
HR+
Luminal
Cetuximab
EGFR
ErbB
7885.042
uM
inf
inf
1.0037 1.0037 0.0000 0.0264
0.1320
0.5912
HCC2185
TNBC
Luminal
Gefitinib
EGFR
ErbB
9420.132
uM
inf
inf
0.4783 0.4783 0.0000 0.1427
0.1330
0.3309
AU565
HER2amp
Luminal
FR180204
ERK1/2
MAPK
10880.149
uM
inf
inf
0.8678 0.8678 0.0000 0.0766
0.1343
1.6289
MDA-MB-436
TNBC
Basal B
Trametinib
MEK
MAPK
7900.012
uM
inf
inf
0.4439 0.4439 0.0000 0.5210
-0.1349
0.8090
HCC1937
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7452.084
uM
inf
inf
0.9680 0.9680 0.0000 -0.0014
0.1350
1.6800
MDA-MB-175-VII
HR+
Luminal
SB-3CT
MMP2/9
MMP
10642.144
uM
inf
inf
0.7684 0.7684 0.0000 0.1437
0.1354
0.6510
600MPE
HR+
Luminal
Purvalanol A
CDK1
CDK
5898.067
uM
inf
inf
0.8837 0.8837 0.0000 0.0867
0.1356
0.6532
MDA-MB-134-VI
HR+
Luminal
Cetuximab
EGFR
ErbB
7877.042
uM
inf
inf
0.9001 0.9001 0.0000 0.0283
0.1356
0.3414
HCC1806
TNBC
Basal A
Erlotinib
EGFR
ErbB
7450.091
uM
inf
inf
1.0500 1.0500 0.0000 -0.0008
0.1356
1.0419
HCC3153
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7466.085
uM
inf
inf
0.9627 0.9627 0.0000 0.0395
0.1367
0.8684
HCC1937
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
7453.098
uM
inf
inf
0.9252 0.9252 0.0000 0.0007
0.1372
1.4660
600MPE
HR+
Luminal
PD184352
MEK
MAPK
12224.155
uM
inf
inf
0.6879 0.6879 0.0000 0.1877
0.1373
1.0378
600MPE
HR+
Luminal
PD184352
MEK
MAPK
12224.155
uM
inf
inf
0.6879 0.6879 0.0000 0.1877
0.1373
1.0378